Current Neuro-Oncology

Volume 7 Number 11
30 November 2005

Home > Publications > Current Neuro-Oncology > Volume 7, Year 2005 > Number 11, 30 November

Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, Lu KV, Yoshimoto K, Huang JH, Chute DJ, Riggs BL, Horvath S, Liau LM, Cavenee WK, Rao PN, Beroukhim R, Peck TC, Lee JC, Sellers WR, Stokoe D, Prados M, Cloughesy TF, Sawyers CL, Mischel PS.
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.
N Engl J Med. 2005 Nov 10;353(19):2012-24∟. doi: 10.1056/NEJMoa051918∟. PMID: 16282176∟. Clinical study. ˍ
Erratum in: N Engl J Med. 2006 Feb 23;354(8):884∟. doi: 10.1056/NEJMx060009∟. Correction. ˍ

Ellison DW, Onilude OE, Lindsey JC, Lusher ME, Weston CL, Taylor RE, Pearson AD, Clifford SC; United Kingdom Children's Cancer Study Group Brain Tumour Committee.
beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.
J Clin Oncol. 2005 Nov 1;23(31):7951-7∟. doi: 10.1200/JCO.2005.01.5479∟. PMID: 16258095∟. Laboratory investigation. ˍ